← Back to Clinical Trials
Recruiting Phase 1 NCT06948136

Acute Effects of THC in Older Adult

Trial Parameters

Condition Age-related Cognitive Decline
Sponsor Yale University
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 60
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2025-06-06
Completion 2027-11-01
Interventions
Delta-9-THC Low DosePlaceboDelta-9-THC Medium Dose

Brief Summary

The primary objective of this study is to determine if increasing age confers greater vulnerability to the acute A) cognitive (e.g., memory, attention, psychomotor function), B) subjective (e.g., anxiogenic and rewarding effects), and C) cardiovascular (heart rate and blood pressure), effects of THC in adults \> 21 years old. The secondary aims of the study are to explore age-related acute effects of THC on electrophysiological indices of information processing (e.g., auditory steady-state response (ASSR), oddball paradigm \[P300\], and resting state cortical noise) and to determine age-related differences in the metabolism of THC.

Eligibility Criteria

* Ability to provide informed consent * No history (current or past) of unstable or serious medical, neurological or psychiatric conditions. * High school education or greater * No positive pregnancy test and/or lactation/ planning to nurse while in this study * English speaking

Related Trials